1-3 of 3
Ezequiel Rivera, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I-II Study of Dose Dense PEG-Filgrastim and GM-CSF as Support for Dose Dense CHOP-R Front Line Therapy for Aggressive Non-Hodgkin's Lymphoma (NHL).

Maribel Cotto, MD, Fernando Cabanillas, MD, Idalia Liboy, MD, Ezequiel Rivera, MD, Orestes A. Pavia, MD, Margarita Bruno
Journal: Blood
Blood (2010) 116 (21): 2789.
https://doi.org/10.1182/blood.V116.21.2789.2789
Published: 2010
Journal Articles

Very Early Post-Treatment PET/CT Scan Performed One Week after First Chemotherapy Course Compared Against the Standard PET after Third Course in Histologically Aggressive Lymphoma (NHL).

Fernando Cabanillas, MD, Jorge Toro, MD, Jorge W. Perdomo, MD, Idalia Liboy, MD, Orestes Pavia, MD, Norman Maldonado, MD, Ezequiel Rivera, MD
Journal: Blood
Blood (2006) 108 (11): 2433.
https://doi.org/10.1182/blood.V108.11.2433.2433
Published: 2006
Journal Articles

High Incidence of Non-Neutropenic Infections Induced by Rituximab Plus Chemotherapy and Associated with Hypogammaglobulinemia: A Frequently Unrecognized and Easily Treatable Complication.

Fernando Cabanillas, MD, Orestes Pavia, MD, Ezequiel Rivera, MD
Journal: Blood
Blood (2005) 106 (11): 2445.
https://doi.org/10.1182/blood.V106.11.2445.2445
Published: 2005